2016-2017 年，美国医疗保险处方药计划中接受处方类阿片的患者同时开具纳洛酮的情况。
Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.
机构信息
Centers for Disease Control and Prevention, Atlanta, Georgia.
National Institutes of Health, Bethesda, Maryland.
出版信息
JAMA. 2019 Aug 6;322(5):462-464. doi: 10.1001/jama.2019.7988.
Abstract
This study uses Medicare Part D data to compare US national and state rates of co-prescribing of naloxone with opioids and benzodiazepines in 2016-2017.
摘要
本研究使用医疗保险部分 D 数据，比较了 2016-2017 年美国全国和各州阿片类药物和苯二氮䓬类药物同时开具纳洛酮处方的比例。
相似文献
1
Naloxone Co-prescribing to Patients Receiving Prescription Opioids in the Medicare Part D Program, United States, 2016-2017.2016-2017 年，美国医疗保险处方药计划中接受处方类阿片的患者同时开具纳洛酮的情况。
JAMA. 2019 Aug 6;322(5):462-464. doi: 10.1001/jama.2019.7988.
2
Analysis of psychiatrists' prescription of opioid, benzodiazepine, and buprenorphine in Medicare Part D in the United States.分析美国医疗保险处方药计划中精神科医生开具阿片类药物、苯二氮䓬类药物和丁丙诺啡处方的情况。
Trends Psychiatry Psychother. 2020 Jan-Mar;42(1):48-54. doi: 10.1590/2237-6089-2019-0015.
3
Use of Opioid Agonist Therapy for Medicare Patients in 2013.2013年医疗保险患者使用阿片类激动剂治疗情况
JAMA Psychiatry. 2016 Sep 1;73(9):990-2. doi: 10.1001/jamapsychiatry.2016.1390.
4
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统，八个州，2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
5
Trends in naloxone co-prescriptions.纳洛酮联合处方的趋势。
Drug Alcohol Depend. 2025 Feb 1;267:112528. doi: 10.1016/j.drugalcdep.2024.112528. Epub 2024 Dec 18.
6
An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.9 个州 2015 年阿片类药物与苯二氮䓬类药物同时处方情况调查
Am J Prev Med. 2019 Nov;57(5):629-636. doi: 10.1016/j.amepre.2019.06.007. Epub 2019 Sep 27.
7
8
Naloxone Prescribing Among Frequent Opioid Prescribers in Medicare Part D from 2013 to 2017: a Retrospective Study.2013年至2017年医疗保险D部分频繁开具阿片类药物处方者中纳洛酮处方情况：一项回顾性研究
J Gen Intern Med. 2021 Feb;36(2):543-545. doi: 10.1007/s11606-020-05872-5. Epub 2020 May 6.
9
State variation in opioid and benzodiazepine prescriptions between independent and nonindependent advanced practice registered nurse prescribing states.独立与非独立高级执业注册护士开处方州之间阿片类药物和苯二氮䓬类药物处方的州差异。
Nurs Outlook. 2016 Jan-Feb;64(1):86-93. doi: 10.1016/j.outlook.2015.10.003. Epub 2015 Oct 22.
10
Prevalence of psychotropic and opioid prescribing among hospice beneficiaries in the United States, 2014-2016.2014-2016 年美国临终关怀受益人群中精神类药物和阿片类药物处方的流行情况。
J Am Geriatr Soc. 2021 Jun;69(6):1479-1489. doi: 10.1111/jgs.17085. Epub 2021 Mar 8.
引用本文的文献
1
A Pilot Assessment of Caregivers' and Patients' Perception of Naloxone Coprescribing in a Pediatric Sickle Cell Population.一项针对儿科镰状细胞病患者群体中护理人员和患者对纳洛酮联合处方认知的试点评估。
J Pediatr Pharmacol Ther. 2025 Aug;30(4):498-503. doi: 10.5863/JPPT-24-00071. Epub 2025 Aug 11.
2
Analysis of different populations accessing online overdose response training and harm reduction supplies (ADORES).分析不同人群获取在线过量用药应对培训和减少伤害供应品的情况（ADORES）。
Harm Reduct J. 2024 Nov 20;21(1):202. doi: 10.1186/s12954-024-01118-3.
3
Clinical Decision Support to Increase Emergency Department Naloxone Coprescribing: Implementation Report.临床决策支持以增加急诊纳洛酮共同处方：实施报告。
JMIR Med Inform. 2024 Nov 6;12:e58276. doi: 10.2196/58276.
4
Iterative Development of a Clinical Decision Support Tool to Enhance Naloxone Coprescribing.用于加强纳洛酮联合处方的临床决策支持工具的迭代开发。
Appl Clin Inform. 2025 Jan;16(1):215-222. doi: 10.1055/a-2447-8463. Epub 2024 Oct 25.
5
Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial.在美国，向接受长期阿片类药物治疗的患者直接提供叙事性纳洛酮和过量用药预防视频的效果：纳洛酮导航随机临床试验
BMJ Public Health. 2024 Jul;2(1). doi: 10.1136/bmjph-2023-000725. Epub 2024 Jul 8.
6
Improving Naloxone Co-prescribing Through Clinical Decision Support.通过临床决策支持改善纳洛酮联合处方
Cureus. 2024 Jul 5;16(7):e63919. doi: 10.7759/cureus.63919. eCollection 2024 Jul.
7
Naloxone co-prescriptions for surgery patients prescribed opioids: A retrospective cohort study.接受阿片类药物治疗的手术患者的纳洛酮联合处方：一项回顾性队列研究。
Surg Pract Sci. 2023 Dec;15. doi: 10.1016/j.sipas.2023.100217. Epub 2023 Sep 11.
8
Electronic Advisories Increase Naloxone Prescribing Across Health Care Settings.电子咨询增加了医疗保健环境中的纳洛酮处方。
J Gen Intern Med. 2023 May;38(6):1402-1409. doi: 10.1007/s11606-022-07876-9. Epub 2022 Nov 14.
9
Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018.2010-2018 年美国按药物品牌和支付方划分的纳洛酮自付费用趋势。
JAMA Health Forum. 2022 Aug 5;3(8):e222663. doi: 10.1001/jamahealthforum.2022.2663.
10
Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process.专家对州级纳洛酮获取法的看法：在线修改德尔菲法的定性分析。
Harm Reduct J. 2022 Jun 8;19(1):64. doi: 10.1186/s12954-022-00645-1.
本文引用的文献
1
Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.阿片类药物过量教育与纳洛酮分发：退伍军人健康管理局国家项目的开展
J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2S):S168-S179.e4. doi: 10.1016/j.japh.2017.01.022.
2
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
Zotero 插件